Key Points Regencell Bioscience looks like a risky bet. It's generated zero revenue for several years in a row. Also, its valuation seems way out of line. 10 stocks we like better than Regencell Bioscience › Shares of Regencell Bioscience Holdings (NASDAQ: RGC) have been on quite a ride since their 2021 initial public offering (IPO), surging 9,800% year to date (as of Nov. 19). That's enough to drive many investors to buy. Why are they buying this growth stock? Some are simply hoping the shares ...

Accessibility StatementSkip Navigation NEW YORK, Nov. 20, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Regencell Bioscience Holdings Limited ("Regencell" or the "Company") (NASDAQ: RGC). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. Also from this source On this news, Regencell's stock price fell $3.09 per share, or 18.56%, to close at $13.56 per share on November 3, 2025. Pomerantz LLP, with offices in New ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FORM 20-F ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the tran ...

We recently compiled a list of the 12 Healthcare Stocks with Insider Buying in 2025. Regencell Bioscience Holdings Limited is one of them. Regencell Bioscience Holdings Limited (NASDAQ:RGC) tops our list for being one of the stocks with insider buying. It is a Hong Kong-based biopharmaceutical company developing Traditional Chinese Medicine (TCM) treatments for neurocognitive disorders such as ADHD and autism spectrum disorder (ASD). A key milestone came on September 21, 2025, when RGC was added to the S ...

Group 1: Stock Market Overview - U.S. stocks exhibited mixed performance, with the Dow Jones index increasing by over 200 points on Wednesday [1] Group 2: Notable Stock Movements - Lyft, Inc. shares surged by 13.5% to $22.92 following the announcement of an expansion plan with Waymo to Nashville, where Lyft's Flexdrive will manage Waymo's fully autonomous vehicles [1] - New Fortress Energy Inc. saw its shares jump 32.3% to $2.6501 after securing a long-term gas supply agreement with the Puerto Rican government [3] - Oruka Therapeutics, Inc. experienced a 14.1% increase in shares to $17.01 after announcing interim Phase 1 results for ORKA-001 and a $180 million private placement [3] - Robo.ai Inc. shares rose by 12.9% to $1.9190 [3] - Roivant Sciences Ltd. gained 12% to $15.89 after reporting Phase 3 results for brepocitinib in treating a debilitating skin-muscle disease [3] - Opendoor Technologies Inc. shares surged by 11.1% to $9.91 [3] - Gevo, Inc. also gained 11.1%, reaching $2.1089 [3] - Blue Gold Limited saw a 10.5% increase to $11.05 [3] - Workday, Inc. shares surged by 9% to $238.63 after an upgrade from Piper Sandler, raising the price target from $220 to $235 [3] - Parsons Corporation gained 6.9% to $80.64 after being awarded a task order for Indo-Pacific Counter-Nuclear Smuggling System Deployment [3] - e.l.f. Beauty, Inc. shares increased by 4.6% to $149.91, with B of A Securities maintaining a Buy rating and raising the price target from $135 to $160 [3]

Group 1 - A significant drop in stock prices of several Chinese micro-cap stocks listed in the US has resulted in investors losing billions of dollars, raising concerns about a potential "pump and dump" scheme [1] - Seven specific stocks, including Concorde International (CIGL.US) and Austin Technology (OST.US), have seen declines exceeding 80% in recent trading days, leading to a total market value loss of $3.7 billion [1] - Prior to the sharp declines, these stocks had experienced substantial increases and were promoted on social media platforms like WhatsApp [1] Group 2 - Brain Regen Technologies (RGC.US) has seen its stock price increase nearly 10,000% this year, with no current evidence linking the company to stock price fluctuations [2] - The FBI reported a 300% increase in complaints related to "pump and dump" stock fraud over the past year, indicating a rise in investor victimization [2] - Fraud groups are reportedly using social media ads and "investment club" promotions to lure investors, sometimes impersonating legitimate brokerage firms or well-known stock analysts [2]

Group 1 - The company is entering a phase of high cash flow generation from previous investments and aims to establish itself as a mature entity, exceeding investor expectations [1] - Despite having debt, the company is focused on leveraging its position for growth [1] - The investment strategy emphasizes a bottom-up approach, concentrating on operational fundamentals and sustainable growth drivers [1] Group 2 - The analyst prioritizes companies in the Consumer Discretionary and Consumer Staples sectors, particularly those with smaller capitalization and low institutional coverage, to identify potential investment opportunities [1] - The investment philosophy combines income and value investing strategies, emphasizing the importance of dividend yield as a risk mitigation criterion [1] - The analysis includes a triangulation approach using valuation by multiples, discounted cash flow (DCF), and dividend yield [1]

Group 1: Stock Splits and Market Trends - A company that has rallied almost 62,000% since its debut is considered a strong buy, while another with over 60,000% gain is viewed as a potential disaster [1] - Investors have shown significant interest in stock splits, particularly forward splits, which lower share prices to make them more accessible to retail investors [2][5] - Reverse splits are generally perceived negatively, often associated with struggling companies trying to avoid delisting [4] Group 2: O'Reilly Automotive - O'Reilly Automotive is highlighted as a strong buy, having completed a 15-for-1 forward stock split, reducing its share price from nearly $1,400 to around $90 [9][8] - The average age of vehicles on U.S. roads has reached 12.8 years, indicating a growing demand for auto parts suppliers like O'Reilly [10] - O'Reilly's distribution network includes 31 distribution centers and around 400 hub stores, ensuring timely availability of parts [12] - The company has spent $26.59 billion on share repurchases since 2011, retiring nearly 60% of its outstanding shares, positively impacting its earnings per share [13] - O'Reilly's forward price-to-earnings (P/E) ratio of 30 represents a 29% premium to its trailing five-year average, but it is expected to deliver sustained high-single-digit to low-double-digit annual EPS growth [14] Group 3: Regencell Bioscience Holdings - Regencell Bioscience Holdings, despite a 60,000% year-to-date increase, is recommended for avoidance due to lack of revenue and unclear commercialization timelines [16][19] - The company has a market cap exceeding $7 billion without generating any revenue, raising concerns about its financial viability [19] - Regencell operates under a going concern warning, indicating potential difficulties in covering liabilities in the next 12 months [21] - The stock's price surge was likely driven by a small tradable float, making future price increases less likely after its 38-for-1 forward split [22]

Market Dynamics - Regencell Bioscience Holdings shares experienced volatility [1]

Core Insights - The stock market's recent performance has been significantly influenced by the rise of artificial intelligence (AI), with PwC estimating a $15.7 trillion boost to the global economy by 2030 [1] - Investor enthusiasm surrounding stock splits, particularly in high-performing companies, has also contributed to the upward trend in major indexes [2] Stock Splits and Market Dynamics - Stock splits are a method for publicly traded companies to adjust their share price and outstanding share count without affecting market capitalization or operational performance [4] - Forward splits are generally favored by investors as they indicate a company's strong operational execution, while reverse splits are often avoided as they suggest financial distress [6][7] Notable Stock Splits in 2025 - In 2025, non-tech companies like Fastenal and O'Reilly Automotive have completed forward splits, reflecting their strong market performance and operational success [9][11] - Fastenal's stock has appreciated over 210,000% since its IPO in 1987, showcasing its deep integration into U.S. industrial supply chains [10] - O'Reilly Automotive's forward split reduced its share price significantly, and the company has executed a robust share repurchase program totaling $25.9 billion since 2011 [12] Regencell Bioscience Holdings Case Study - Regencell Bioscience Holdings executed a 38-for-1 forward stock split, reducing its share price from $595 to under $16, despite having no revenue or commercialized products [17][19] - The company reported a comprehensive loss of $4.32 million for fiscal 2024, with only 12 employees, raising concerns about its operational viability [20] - Regencell's stock surge of 60,120% in a short period raises questions about the sustainability of its valuation, which reached nearly $39 billion without any sales [18][19][24]